Skip to main content
Top
Published in: Diabetology International 1/2022

01-01-2022 | Ileus | Case Report

Formation of large abscess tumor including gallstone in ileum during therapy for hyperosmolar hyperglycemic syndrome: a case report

Authors: Takatoshi Anno, Fumika Minakawa, Ryo Shigemoto, Fumiko Kawasaki, Katsunori Ishii, Hirofumi Kawamoto, Koichi Tomoda, Kohei Kaku, Hideaki Kaneto

Published in: Diabetology International | Issue 1/2022

Login to get access

Abstract

Hyperosmolar hyperglycemic status (HHS) is one of the most serious acute metabolic complications of diabetes mellitus (DM) and the patients with type 2 DM are immunocompromised host, especially when glycemic control is poor. Under hyperglycemic conditions, we have to pay much attention even for rare infection. Bouveret’s syndrome is a rare type of gallstone ileus together with duodenal obstruction secondary to the passage of a stone through a cholecystoduodenal fistula. Herein, we reported a rare case with formation of large abscess tumor, including necrotic ileum and gallstone after taking therapy for HHS. She was under more rare conditions rather than Bouveret’s syndrome, because large abscess tumor was formed not in the duodenal bulb but in the ileum together with necrotic ileitis and abdominal abscess with impacted gallstone. We should bear in mind that T2DM patients are immunocompromised host in particular under untreated or poorly controlled conditions and thereby they could have rare inflammatory diseases such as a large abscess tumor.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335–43.CrossRef Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335–43.CrossRef
2.
go back to reference Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510–3.CrossRef Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510–3.CrossRef
3.
go back to reference Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50:549–54.CrossRef Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50:549–54.CrossRef
4.
go back to reference Aune D, Vatten LJ. Diabetes mellitus and the risk of gallbladder disease: a systematic review and meta-analysis of prospective studies. J Diabetes Complicat. 2016;30:368–73.CrossRef Aune D, Vatten LJ. Diabetes mellitus and the risk of gallbladder disease: a systematic review and meta-analysis of prospective studies. J Diabetes Complicat. 2016;30:368–73.CrossRef
5.
go back to reference Bouveret L. Stenose du pylore adhérent à la vesicule [Article in French]. Rev Med. 1896;16:1–16. Bouveret L. Stenose du pylore adhérent à la vesicule [Article in French]. Rev Med. 1896;16:1–16.
6.
go back to reference Cappell MS, Davis M. Characterization of Bouveret’s syndrome: a comprehensive review of 128 cases. Am J Gastroenterol. 2006;101:2139–46.CrossRef Cappell MS, Davis M. Characterization of Bouveret’s syndrome: a comprehensive review of 128 cases. Am J Gastroenterol. 2006;101:2139–46.CrossRef
7.
go back to reference Koulaouzidis A, Moschos J. Bouveret’s syndrome. Narrative review. Ann Hepatol. 2007;6:89–91.CrossRef Koulaouzidis A, Moschos J. Bouveret’s syndrome. Narrative review. Ann Hepatol. 2007;6:89–91.CrossRef
Metadata
Title
Formation of large abscess tumor including gallstone in ileum during therapy for hyperosmolar hyperglycemic syndrome: a case report
Authors
Takatoshi Anno
Fumika Minakawa
Ryo Shigemoto
Fumiko Kawasaki
Katsunori Ishii
Hirofumi Kawamoto
Koichi Tomoda
Kohei Kaku
Hideaki Kaneto
Publication date
01-01-2022
Publisher
Springer Singapore
Keywords
Ileus
Diabetes
Published in
Diabetology International / Issue 1/2022
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-021-00540-3

Other articles of this Issue 1/2022

Diabetology International 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine